Published in AIDS Weekly, July 3rd, 2006
Study 1: Carbazolone-containing alpha,gamma-diketo acids inhibit HIV integrase.
"Since alpha,gamma-diketo acid (DKA) compounds were identified as potent and selective inhibitors for HIV integrase, numerous structural modification studies have been carried out to search for a clinical candidate as a supplement for the highly active antiretroviral therapy regimen.
"Due to the lack of structural information on inhibitor-integrase interactions, a comprehensive structure-activity relationship study is necessary," researchers in the United States report.
...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-07-03)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.